Biotechnology Research · Baden-Württemberg
We are a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. At our sites in Germany and the U.S. we offer biopharmaceutical process development and manufacturing as well as related consulting activities, project management & regulatory support. In 1983, we were an industry pioneer, with the world’s first market approval of a native interferon-ß (Fiblaferon). Since then, we have supported numerous modalities on their way from concept to market, regularly contributing to biologics reaching market approval. In 2023 alone, we contributed to nearly 25% of all FDA-approved biologics. We empower our partners to help patients with serious or rare diseases. With our dedication and expertise in development and manufacturing we convert medical research into outstanding biopharmaceuticals. -Experts in cell culture bioprocess development and manufacturing -Full-service solutions, addressing clinical and commercial needs -Global leader in mammalian cell culture -Tailored solutions -Long-term partnerships rooted in trust -50 years of experience As a global leading CDMO, we support your process development and manufacturing needs for biopharmaceuticals. We also support you with the creation of approval documents at an international level. Many years of experience and expertise in finding best-fit solutions, as well as certified quality management and advanced technologies, ensure our high-quality standards. Furthermore, our client-oriented consulting activities, including project management and regulatory support, guarantee your project’s success. With our full-service offering, we are your CDMO partner of choice.